Tripping Into Old Age: Could a Psychedelic Mushroom Be the Anti-Inflammatory Drug Geriatrics Forgot? (opens in new tab)

A Polish research group argues that psilocybin is uniquely suited to older patients because it simultaneously hits three age-related targets — mood, neuroplasticity, and chronic inflammation — in a single, short-acting dose with few drug interactions. The catch: almost none of the supporting evidence comes from people over 65. Getting older is, increasingly, understood as a slow-burning inflammatory event. Scientists call it “inflammaging” — a persistent, low-grade rise in immune signals such...